SCHEMBL29137920

SCHEMBL29137920

O=C(O)c1ccc(F)c(CF)c1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
WDR5 P61964 1/20 0.40
ACLY P53396 4/20 0.39
HNF4A P41235 2/20 0.39
ACMSD Q8TDX5 2/20 0.39
TTR P02766 1/20 0.39
DCLRE1B Q9H816 2/20 0.38
DCLRE1A Q6PJP8 1/20 0.38
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 1/20 0.38
ALB P02768 1/20 0.37
KDM4E B2RXH2 2/20 0.37
CHRM1 P11229 1/20 0.36
DHODH Q02127 1/20 0.36
MAPT P10636 1/20 0.36
PIM1 P11309 1/20 0.36
GFER P55789 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29137938 0.87 AKR1C2 (0.42) AKR1C2AKR1C1WDR5ACLYHNF4A
SCHEMBL28166374 0.76 AKR1C2 (0.45) AKR1C2AKR1C1WDR5ACLYHNF4A
SCHEMBL332581 0.75 ALDH1A1 (0.57) WDR5HNF4AACMSDDCLRE1BDCLRE1A
SCHEMBL22190013 0.74 ALDH1A1 (0.46) WDR5HNF4AACMSDDCLRE1BDCLRE1A
SCHEMBL3656083 0.73 ALB (0.57) TTRALDH1A1ALOX15ALBKDM4E
SCHEMBL15057790 0.72 MEN1 (0.50) AKR1C2AKR1C1ACLYHNF4AACMSD
SCHEMBL901069 0.72 ACMSD (0.61) WDR5ACLYHNF4AACMSDDCLRE1B
SCHEMBL11691857 0.71 FABP4 (0.43) WDR5HNF4AACMSDDCLRE1BDCLRE1A
SCHEMBL30209232 0.71 WDR5 (0.44) WDR5ACLYHNF4AACMSDDCLRE1B
SCHEMBL9756514 0.71 WDR5 (0.47) WDR5HNF4AACMSDDCLRE1BDCLRE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117062804-A 1, 3-substituted cyclobutyl derivatives and their use 诺华股份有限公司 2023-11-14 CN disclosed